GPS Cancer works by leveraging advanced genomic sequencing technologies to decode the DNA, RNA, and protein expressions within a cancerous tumor. This process allows for the identification of mutations, gene expression changes, and protein anomalies that are driving the cancer. The data is then analyzed and compared against a vast database of known cancer markers and treatments to generate a detailed report.